Vistin Pharma — Director's Dealing 2016

Jan 6, 2016

CORRECTION: Mandatory Notification of Trade

CORRECTION: Mandatory Notification of Trade

This is a correction of the announcement from 16:06 06.01.2016 CET. Reason for

the correction: Dates missing

Gitte Jensen Wegge, Vice President Operations at Vistin Pharma ASA, and a

primary insider, has on 6 January sold 4,100 shares in Vistin Pharma at an

average sales price of NOK 20.20 per share. Gitte Jensen Wegge also sold 200

shares on 5 January, at an average sales price of NOK 21.40 per share, and sold

700 shares on 4 January, at an average sales price of NOK 21.50 per share.

Following these sales, Gitte Jensen Wegge holds 5,000 shares in Vistin Pharma.

[HUG#1977127]